The Opioid Used Only in Hospitals — Too Powerful for Home Prescribing
Remifentanil is the opioid used almost exclusively in hospitals because its potency and ultra-rapid onset make it far too dangerous for outpatient...
Category Tools
New Autoimmune Drug Approved That Targets a Never-Before-Seen Pathway
Several new autoimmune drugs targeting previously untapped biological pathways have reached approval or late-stage development, and they represent the...
Why Some Patients Do Better Off Medication Than On It
Some patients genuinely do better off certain medications because the side effects, drug interactions, and cognitive burden of treatment can outweigh the...
The Antiviral Drug Approved for a Childhood Virus Adults Still Get
The antiviral drug in question is acyclovir, originally approved decades ago to treat herpes simplex and varicella-zoster virus — the same virus...
New Oral Drug for Primary Progressive MS Approved — Years in the Making
Despite the hopeful framing of this headline, the full picture requires an honest clarification: as of March 2026, no oral drug has yet received FDA...
The Blood Test That Tells You If Your Medication Is Working
Therapeutic drug monitoring, often called TDM, is a blood test that measures the concentration of a specific medication in your bloodstream to determine...
New Atrial Fibrillation Pill Approved — How It Compares to Older Drugs
Despite headlines suggesting a new atrial fibrillation pill has been approved, the reality is more nuanced — and arguably more interesting.
New Oral Testosterone Gets FDA Approval — Why This Is Different
For decades, men with clinically low testosterone faced a narrow set of options: needles, gels that could rub off on family members, or older oral pills...
This Sleeping Pill Works Within 7 Minutes — FDA Just Approved It
No, there is no FDA-approved sleeping pill that works within seven minutes. The headline circulating online — "This Sleeping Pill Works Within 7 Minutes —...
New Drug Approved for Postpartum Depression Works in 3 Days
In August 2023, the FDA approved zuranolone, sold under the brand name Zurzuvae, as the first oral medication specifically designed to treat postpartum...